A Phase 2 Randomized Double-blind Placebo-controlled Repeat-dose Study of KB001-A in Subjects with Cystic Fibrosis Infected with Pseudomonas aeruginosa
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to determine if multiple doses of KB001-A are safe and effective in people with Cystic Fibrosis and chronic Pseudomonas infection.
Description
The purpose of this study is to determine if multiple doses of KB001-A are safe and effective in people with Cystic Fibrosis and chronic Pseudomonas infection.
Details
| Condition | Cystic Fibrosis |
|---|---|
| Age | 12years - 50years |
| Clinical Study Identifier | TX2983 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.